STAAR Surgical logo

STAAR SurgicalNASDAQ: STAA

Profile

Sector:

Healthcare

Country:

United States

IPO:

24 February 1992

Next earnings report:

26 February 2025

Last dividends:

N/A

Next dividends:

N/A
$1.30 B
-75%vs. 3y high
76%vs. sector
-74%vs. 3y high
85%vs. sector
-85%vs. 3y high
69%vs. sector
-84%vs. 3y high
55%vs. sector

Price

after hours | Wed, 20 Nov 2024 21:20:00 GMT
$26.32+$0.18(+0.69%)

Dividend

No data over the past 3 years
$88.59 M$77.84 M
$88.59 M$9.98 M

Analysts recommendations

Institutional Ownership

STAA Latest News

A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts
zacks.com04 November 2024 Sentiment: POSITIVE

Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
seekingalpha.com30 October 2024 Sentiment: POSITIVE

STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, October 30th, 2024.

Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
zacks.com12 August 2024 Sentiment: POSITIVE

Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

STAAR Surgical Company (STAA) Q2 2024 Earnings Call Transcript
seekingalpha.com09 August 2024 Sentiment: POSITIVE

STAAR Surgical Company (NASDAQ:STAA ) Q2 2024 Earnings Conference Call August 7, 2024 4:15 PM ET Company Participants Brian Moore – Vice President of Investor Relations Tom Frinzi - Chair of the Board, President & Chief Executive Officer Patrick Williams - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Tom Stephan - Stifel Margaret Kaczor Andrew - William Blair David Saxon - Needham Anthony Petrone - Mizuho George Sellers - Stephens John Young - Canaccord Operator Greetings and welcome to the STAAR Surgical Second Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, August 7, 2024.

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
zacks.com07 August 2024 Sentiment: POSITIVE

Staar Surgical (STAA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.40 per share a year ago.

Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

Examine how Staar Surgical's (STAA) international revenue results impact financial analysts' forecasts on Wall Street and the stock's future outlook.

Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Zacks Investment Research05 April 2024 Sentiment: POSITIVE

Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

What's going on with STAAR Surgical shares?
Invezz05 April 2024 Sentiment: POSITIVE

STAAR Surgical (NASDAQ: STAA) received an upgrade from William Blair on Friday. The stock has been moved from Market Perform to Outperform status.

Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research27 February 2024 Sentiment: POSITIVE

The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript
Seeking Alpha26 February 2024 Sentiment: POSITIVE

STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript

What type of business is STAAR Surgical?

STAAR Surgical Company is a leading manufacturer of lenses used worldwide in corrective surgery. The corporation has been in operation since 1982 and is based in Springfield, Massachusetts. STAAR Surgical Company designs, develops, manufactures, and markets implantable lenses for the eyes and systems used to deliver lenses to the eye. STAAR conducts business worldwide, with approximately 95% of its sales volume coming from outside the US. The company sells its products in over 75 countries, through direct sales in Japan, Spain, the US, Germany, Canada, the UK, and Singapore, and through distributors and representatives in China, Korea, and India.

What sector is STAAR Surgical in?

STAAR Surgical is in the Healthcare sector

What industry is STAAR Surgical in?

STAAR Surgical is in the Medical Instruments & Supplies industry

What country is STAAR Surgical from?

STAAR Surgical is headquartered in United States

When did STAAR Surgical go public?

STAAR Surgical initial public offering (IPO) was on 24 February 1992

What is STAAR Surgical website?

https://www.staar.com

Is STAAR Surgical in the S&P 500?

No, STAAR Surgical is not included in the S&P 500 index

Is STAAR Surgical in the NASDAQ 100?

No, STAAR Surgical is not included in the NASDAQ 100 index

Is STAAR Surgical in the Dow Jones?

No, STAAR Surgical is not included in the Dow Jones index

When was STAAR Surgical the previous earnings report?

No data

When does STAAR Surgical earnings report?

The next expected earnings date for STAAR Surgical is 26 February 2025